| Name | Title | Contact Details |
|---|
Xanitos is a management company that provides hospital housekeeping, patient transport, and central laundries services. It is differentiated by its patented XRO System for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service, believing that by so doing, profits will follow. Graeme Crothall, founder and CEO, has 45 years’ experience in hospital housekeeping and during that time he has founded and led four successful companies in the industry whose revenues today exceed $2.5 billion. In 2008 Graeme founded Xanitos by acquiring two small companies, one of which owned the XRO patient room cleaning system, and continuing his track-record of providing top quality service, attracting and holding excellent operations management, and always growing the companies he leads. Xanitos continues to grow because of its patented XRO System for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service.
Diasys Corp is a Waterbury, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PESI is a Eau Claire, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology. Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed. In order to achieve its goal the company first focussed on an application in the diagnosis and treatment of colorectal cancers (CRC). CRC is the second leading cause of cancer death with an estimated annual worldwide death toll of 510,000 people. More than 1 million new cases are diagnosed every year. However 90-100% of colorectal cancers can be avoided if diagnosed early on